The Study
Therapeutic PCSK9 targeting: Inside versus outside the hepatocyte?
This study is like a teacher’s summary of what other scientists have found. It doesn’t do a new experiment, so it can’t prove anything new. It just helps us understand what we already know about PCSK9 drugs.
Analysis score
Maximum 5 for a narrative review.
Where the score came from
Some medicines grab bad cholesterol helpers in the blood, while others stop the body from making them in the liver. Both help lower bad cholesterol even more when used with regular pills.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 51 / 100
Quality score
Based on clinical experience or non-systematic literature reviews. The lowest level of evidence as they are most susceptible to bias and personal perspective.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes, both help people with high cholesterol get to safer levels, especially when regular medicine isn't enough.
- 2One type of medicine lowers bad cholesterol by 60%, another by 50%.
- 3One causes the body to make more of the helper protein, the other makes less.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Pharmacology & therapeutics
Year
2025
Authors
A. Corsini, Henry N. Ginsberg, M. Chapman
Related Content
Claims (5)
Blocking a protein called PCSK9 with certain drugs helps your body remove bad cholesterol from your blood more effectively.
Inclisiran is a type of medicine that helps lower bad cholesterol by turning down a protein in the liver. It works longer than some other cholesterol drugs, so you don’t need to take it as often.
One type of cholesterol drug makes the body produce more of a protein called PCSK9, while another type actually reduces it — so they work in opposite ways even though they target the same thing.
Two newer cholesterol drugs, when added to the strongest statins, can cut bad cholesterol by another half — helping high-risk patients get their levels down to what doctors recommend.
These special lab-made antibodies grab onto a protein in your blood that messes with cholesterol cleanup, so your body can get rid of bad cholesterol better and lower your chances of heart problems.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.